Posicor's removal from the market

Posicor's removal from the market, less than a year after itwas approved, shows how hard it is to predict drug interactions.

Posicor inhibits cytochrome P450 enzymes that are important formetabolizing many other drugs. This can allow other drugs to buildup to toxic levels...or prevent the formation of active metabolites.

Posicor (mibefradil) can interact with more than 25 drugsincluding other calcium blockers...beta-blockers...erythromycin...lovastatin...digoxin...and quinidine.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote